- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Feb 6, 2025 | 75.73M sh |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $3.09M |
| Long Term Debt | Q1 2025 · Sep 29, 2024 | $2.69M |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $2.66M |
| Cash And Equivalents | Q1 2025 · Sep 29, 2024 | $2.49M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $1.47M |
| Current Liabilities | Q1 2025 · Sep 29, 2024 | $2.56M |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $4.56M |
| Total Liabilities | Q1 2025 · Sep 29, 2024 | $5.25M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $3.38M |
| Current Assets | Q1 2025 · Sep 29, 2024 | $4.16M |
| Total Assets | Q1 2025 · Dec 29, 2024 | $18.7M |
| Total Assets | Q1 2025 · Sep 29, 2024 | $19.19M |
| Total Assets restated | Q1 2025 · Dec 31, 2023 | $19.19M |
| Short Term Investments | Q1 2025 · Sep 29, 2024 | $835.07K |
| Shares Diluted restated | Q1 2025 · Dec 31, 2023 | 75.58M sh |
| Capex | Q1 2025 · Dec 31, 2023 | $230.17K |
| Operating Cash Flow restated | Q1 2025 · Dec 31, 2023 | −$91.08K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $14.68M |
| Stockholders Equity | Q1 2025 · Oct 1, 2023 | $14.99M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.00 |
| Sga Expense restated | Q1 2025 · Dec 31, 2023 | $1.7M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$369.26K |
| Operating Income | Q1 2025 · Dec 31, 2023 | −$458.9K |
| Revenue | Q1 2025 · Dec 31, 2023 | $1.9M |